MED

Medifast, Inc. (MED) PESTLE Analysis Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Overall Score

Score: 5.8 (Moderate)

Political

Score:

No material political catalysts or regulatory changes were provided in the latest news flow.

The company remains exposed to standard healthcare reimbursement and policy risk, but no new month-over-month developments were reported.

Economic

Score:

Valuation remains depressed with EV/Sales at 0.30x and Price/Sales at 0.44x, suggesting the market is still pricing in weak growth or execution risk.

Liquidity is strong with a current ratio of 4.86x and cash per share of 15.25, but profitability remains negative with ROE at -12.68% and ROA at -9.83%.

Social

Score:

No new social or demand-shift news was reported this month.

The business still appears to operate in a stable healthcare demand environment, but there is no fresh evidence of accelerating end-market adoption.

Technological

Score:

R&D intensity remains low at 0.35% of revenue, indicating limited near-term technology investment.

No new product, platform, or innovation announcements were reported in recent news.

Legal

Score:

No new litigation, compliance, or regulatory actions were reported in the latest news.

The company continues to face baseline healthcare legal and reimbursement risk, but there is no fresh evidence of escalation.

Environmental

Score:

No environmental developments or sustainability-related disclosures were reported this month.

Environmental exposure appears limited relative to the broader healthcare sector, with no new material change indicated.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Medifast, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →

Invetso is not affiliated with or regulated by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other financial regulatory authority. The analyses, scores and all the information provided by Invetso are strictly for informational purposes only and do not constitute financial advice, recommendations, or an offer to buy or sell any securities. Invetso is not a registered financial advisor, broker-dealer, or investment advisor, and it does not provide personalized investment, legal, or tax advice. The content provided on this website is not intended to serve as a substitute for professional advice. Users should conduct their own research and consult with a qualified financial advisor before making any investment decisions. All analysis, data, and information presented on this site are based on publicly available information and should be used at the user’s own risk. Invetso does not guarantee the accuracy, completeness, or timeliness of any information or data provided, nor does it endorse any specific securities, companies, or strategies. Any reliance you place on such information is strictly at your own risk. While we strive to provide accurate and up-to-date information, Invetso makes no warranties or representations regarding the completeness, accuracy, or reliability of any analyses or data on our platform, and any such information is subject to the terms and conditions of the Invetso Terms of Service. Our analyses are generated using AI technologies and AI-generated content may contain errors or inaccuracies. Use the information at your own risk. Our platform may contain links to third-party websites, for which we are not responsible for the content or accuracy of information. Invetso shall not be liable for any loss or damage arising from the use of our services. By using this website, you agree that Invetso is not responsible for any losses, damages, or financial outcomes that may result from your use of the information, tools, or resources provided. We recommend consulting with a licensed financial professional before making any investment decisions.

For more details, please refer to our Terms of Service and Privacy Policy.